Novo Nordisk and Mylan Battle Over Generic Versions of Victoza

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 22, 2019 at 5:22 PM.

  1. #1 cafead, Aug 22, 2019 at 5:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Denmark’s Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan. The suit is an attempt to block Mylan from marketing a generic version of Novo Nordisk’s diabetes drug Victoza (liraglutide).

    article source
     
    Quote

Reply to Thread